Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Oligonucleotide SynthesisMarketwas valued at USD 1.28 billion in 2016 and is projected to reach USD 3.15 billion by 2025, growing at a CAGR of 10.45% from 2017 to 2025.
Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Technological Advancements and R&D Investments in Synthetic Biology
1.2 Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
1.3 Increasing R&D Expenditure in Pharmaceutical & Biotechnology Companies
1.4 Rise in Venture Capital Investments
1.5 Growing Focus on Conferences to Increase Awareness Among Researchers
2. Market Restraints
2.1 Price Erosion of Synthesized Oligos
2.2 Lack of Regulations for Therapeutic Oligos
Market Segmentation:
1. Global Oligonucleotide Synthesis Market, by End User:
1.1 Academic Research Institutes
1.2 Pharmaceutical and Biotechnology Companies
1.3 Diagnostic Laboratories
1.4 Other End Users
2. Global Oligonucleotide Synthesis Market, by Application:
2.1 Research
2.1.1 PCR
2.1.2 QPCR
2.1.3 Sequencing
2.1.4 Gene Synthesis
2.1.5 Other Research Applications
2.2 Diagnostics
2.3 Therapeutics
2.3.1 Rnai
2.3.2 Nucleic Acid Aptamers
2.3.3 DNA/Antisense Oligos
2.3.4 Immunotherapy Applications
3. Global Oligonucleotide Synthesis Market, by Products and Services:
3.1 Synthesized Oligonucleotides
3.1.1 Synthesized Oligonucleotides Market, By Product
3.1.1.1 Primers
3.1.1.2 Probes
3.1.1.3 Large-Scale Synthesis Oligos
3.1.1.4 Intermediate-Scale Synthesis Oligonucleotides
3.1.1.5 Linkers and Adaptors
3.1.2 Synthesized Oligonucleotides Market, By Service
3.1.2.1 Custom Oligonucleotides
3.1.2.2 Pre-Designed Oligonucleotides
3.2 Reagents
3.3 Equipment
4. Global Oligonucleotide Synthesis Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Integrated DNA Technologies, Inc.
2. Merck KGaA
3. Eurofins Genomics
4. Thermo Fisher Scientific Inc.
5. Bioautomation Corporation
6. Agilent Technologies, Inc.
7. Eurogentec S.A.
8. General Electric (GE) Company
9. LGC Biosearch Technologies, Inc.
10. Nitto Denko Avecia Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Oligonucleotide SynthesisMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.